153Sm-EDTMP

Abstract

Get full access to this article

View all access options for this article.

References

Holmes RA : [153Sm] EDTMP: A potential therapy for bone cancer pain. Semin Nucl Med 22:41-45, 1992

Lattimer JC , Corwin LA , Stapleton J. , et al: Clinical and clinicopathologic response of canine bone tumor

patients to treatment with samarium- 153EDTMP. J Nucl Med 31:1316-1325, 1990

Lattimer JC , Corwin LA , Stapleton J. , et al: Clinical and clinicopathologic effects of samarium-153-EDTMP administered intravenously to normal beagle dogs. J Nucl Med 31:586-593, 1990

Singh A. , Holmes RA , Farhangi M. , et al: Human pharmacokinetics of samarium- 153-EDTMP in metastatic cancer. J Nucl Med 30:1814-1818, 1989

Turner JH , Martindale AA , Gorby P. , et al: Samarium-153-EDTMP therapy of disseminated skeletal metastases . Eur J Nucl Med 15:784-795, 1989

Bayouth JE , Macey DJ , Kasi LP , et al: Dosimetry and toxicity of 153-Sm-EDTMP administered for bone pain due to skeletal metastases. J Nucl Med 35:63-69, 1994

Eary JF , Collins C. , Stabin M. , et al: Samarium-153-EDTMP biodistribution and dosimetry estimation . J Nucl Med 34:1031-1036, 1993

Holmes RA , Farhangi M. : Dose tolerance of Sm-153-EDTMP in metastatic bone cancer. Proceedings of the 35th Annual Meeting. J Nucl Med 29:775, 1988 (abstr)